Physician profile
Sheryl Ann Knott
NPI 1013587575
$14,226.87
in general payments reported to CMS, 2019-2025
71 companies · $2,666 in 2025
The $2,666 reported for 2025 was more than what 97% of Clinical Nurse Specialist providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $771 · 2022: $3,504 · 2023: $3,736 · 2024: $3,550 · 2025: $2,666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,262 · Education: $690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,261.71 |
| Education | $689.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,449.65 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $1,267.13 | 2021-2025 | Enhertu, Imfinzi, Lynparza |
| Incyte Corporation | $718.10 | 2021-2025 | Jakafi, Monjuvi, Zynyz |
| Astellas Pharma US INC | $701.33 | 2021-2025 | Xospata, Padcev, Xtandi |
| Seagen INC. | $511.07 | 2021-2025 | Padcev, Tukysa, Tivdak |
| Lilly USA, LLC | $503.16 | 2022-2025 | Jaypirca, Verzenio, Retevmo |
| Amgen INC. | $463.97 | 2021-2023 | Kyprolis, Lumakras, Xgeva |
| Pfizer INC. | $446.43 | 2021-2025 | |
| Exelixis INC. | $430.61 | 2021-2025 | Cabometyx |
| Janssen Biotech, INC. | $397.22 | 2021-2025 | Rybrevant, Erleada, Akeega |
| E.R. Squibb & Sons, L.L.C. | $366.42 | 2022-2025 | Reblozyl, Opdivo |
| Glaxosmithkline, LLC. | $320.80 | 2021-2025 | Ojjaara, Jemperli, Zejula |
| Daiichi Sankyo INC. | $316.35 | 2021-2025 | Enhertu |
| Eisai INC. | $303.32 | 2022-2025 | |
| Gilead Sciences, INC. | $290.26 | 2022-2025 | Trodelvy |
Show all 71 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $288.92 | 2021-2025 | |
| Genentech USA, INC. | $259.53 | 2022-2024 | Phesgo, Tecentriq, Venclexta |
| Merck Sharp & Dohme LLC | $234.32 | 2024-2025 | Keytruda, Lynparza, Welireg |
| Ipsen Biopharmaceuticals, INC | $232.43 | 2021-2025 | Onivyde, Tazverik, Somatuline Depot |
| Abbvie INC. | $226.47 | 2021-2025 | |
| Celgene Corporation | $224.06 | 2022-2025 | Reblozyl, Pomalyst, Onureg |
| Rigel Pharmaceuticals, INC. | $214.86 | 2021-2024 | Tavalisse, Rezlidhia |
| Bayer Healthcare Pharmaceuticals INC. | $200.94 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.60 | 2021-2025 | Gilotrif |
| Beigene USA, INC. | $185.68 | 2021-2025 | Brukinsa, Tevimbra |
| Takeda Pharmaceuticals U.S.A., INC. | $183.11 | 2021-2024 | Fruzaqla, Vonvendi |
| Pharmacyclics LLC, An Abbvie Company | $181.42 | 2022-2023 | Imbruvica, Epkinly |
| Emd Serono, INC. | $176.25 | 2023-2025 | Bavencio |
| Pharmaessentia USA Corporation | $161.25 | 2024-2025 | Besremi |
| Regeneron Healthcare Solutions, INC. | $160.75 | 2022-2025 | Libtayo, Lynozyfic |
| Sobi, INC | $156.72 | 2022-2025 | |
| Inari Medical, INC. | $155.72 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Morphosys, US INC. | $151.05 | 2021-2023 | Monjuvi |
| Array Biopharma INC | $145.62 | 2021-2025 | Braftovi, Mektovi, Lorbrena |
| Boston Scientific Corporation | $139.50 | 2022 | |
| Fennec Pharmaceuticals, INC. | $118.62 | 2025 | Pedmark |
| Progenics Pharmaceuticals, INC. | $110.92 | 2023 | Pylarify |
| Dendreon Pharmaceuticals LLC | $109.23 | 2024 | Provenge |
| Biohaven Pharmaceutical Holding Company Ltd. | $107.58 | 2022 | |
| Epizyme, INC. | $105.44 | 2021-2022 | |
| G1 Therapeutics, INC. | $100.90 | 2022-2023 | Cosela |
| Pharmacosmos Therapeutics INC. | $100.25 | 2023-2025 | Monoferric, Cosela |
| Spectrum Pharmaceuticals INC. | $94.13 | 2023-2025 | Rolvedon |
| Karyopharm Therapeutics INC. | $88.85 | 2021-2025 | Xpovio |
| Aveo Pharmaceuticals, INC. | $71.05 | 2022-2025 | |
| Beone Medicines USA, INC. | $70.90 | 2025 | Brukinsa, Tevimbra |
| Alexion Pharmaceuticals, INC. | $70.83 | 2022-2023 | Ultomiris |
| Myriad Genetic Laboratories, INC. | $67.19 | 2022-2025 | Myrisk |
| Legend Biotech USA INC. | $60.74 | 2024-2025 | Carvykti |
| Adaptive Biotechnologies Corporation | $54.55 | 2022-2025 | Clonoseq |
| Adc Therapeutics America, INC. | $52.54 | 2022-2025 | |
| Mirati Therapeutics, INC. | $52.24 | 2023 | Krazati |
| Alnylam Pharmaceuticals INC. | $47.23 | 2021-2023 | Givlaari |
| Iovance Biotherapeutics, INC. | $32.90 | 2025 | Amtagvi |
| Puma Biotechnology, INC. | $31.72 | 2024-2025 | |
| Caris Mpi, INC. | $31.44 | 2025 | Mi Cancer Seek |
| Tersera Therapeutics LLC | $29.05 | 2023 | Xermelo |
| Blueprint Medicines Corporation | $28.06 | 2025 | Ayvakit |
| Amag Pharmaceuticals, INC. | $23.95 | 2021 | |
| Sirtex Medical INC | $20.97 | 2025 | Sir-Spheres Microspheres |
| Dova Pharmaceuticals | $19.59 | 2021 | |
| Stemline Therapeutics INC. | $19.50 | 2023 | Orserdu |
| Heron Therapeutics, INC. | $19.29 | 2022 | |
| Kyowa Kirin, INC. | $18.04 | 2025 | |
| Apellis Pharmaceuticals, INC. | $17.95 | 2023 | Empaveli |
| Horizon Therapeutics Plc | $17.94 | 2022 | |
| Genmab U.S., INC. | $17.86 | 2024 | Epkinly |
| Taiho Oncology, INC. | $17.57 | 2025 | |
| Janssen Pharmaceuticals, INC | $15.75 | 2022 | |
| Servier Pharmaceuticals LLC | $14.59 | 2022 | |
| Azurity Pharmaceuticals, INC. | $13.49 | 2025 | Danziten, Vivimusta |
Drugs and devices associated with these payments
Enhertu $578Kisqali $357Padcev $323Imfinzi $259Cabometyx $252Reblozyl $252Fabhalta $249Keytruda $234Lynparza $231Lenvima $220Monjuvi $215Jakafi $214Promacta $203Tavalisse $169Rezlidhia $169Tukysa $168Xospata $163Besremi $161Piqray $161Brukinsa $159Venclexta $158Ct Thrombectomy System Kit $156Flowtriever Catheter, S $156Sarclisa $143Ibrance $141Jaypirca $140Imbruvica $139Ojjaara $139Zejula $129Jemperli $129Bavencio $125Pedmark $119Kyprolis $117Onivyde $117Verzenio $117Scemblix $116Trodelvy $115Lutathera $114Pylarify $111Provenge $109Braftovi $104Nubeqa $101Xtandi $100Rolvedon $94.13Phesgo $89.86Libtayo $89.14Mektovi $88.84Pluvicto $85.28Cosela $83.95Xofigo $81.70Rybrevant $81.20Lorbrena $80.30Retevmo $78.07Gilotrif $76.43Tecentriq $72.15Monoferric $72.02Carvykti $69.26Opdivo $66.05Tasigna $65.82Stivarga $61.56Welireg $61.45Elrexfio $60.17Lunsumio $57.58Orgovyx $56.13Adcetris $54.25Tazverik $52.56Krazati $52.24Erleada $50.70Akeega $50.70Somatuline Depot $48.77Fruzaqla $46.14Vonjo $45.92Perjeta $44.93Alecensa $44.93Bosulif $44.12Tevimbra $43.70Darzalex $43.02Epkinly $42.99Pomalyst $42.81Polivy $42.16Vitrakvi $42.11Zynyz $41.04Clonoseq $39.37Vonvendi $39.03Myrisk $38.72Talzenna $38.60Doptelet $37.11Xpovio $35.49Amtagvi $32.90Lumakras $32.88Fotivda $32.67Vectibix $32.37Nplate $32.37Xgeva $32.37Lynozyfic $31.79Mi Cancer Seek $31.44Tecvayli $30.45Rozlytrek $30.03Vyloy $29.95Ultomiris $29.87
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheryl Knott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.